Future directions in the management of pain by intraspinal drug delivery

Journal of Pain and Symptom Management

Volumn 20, Issue 2, 2000, Pages

  Bennett, Gary ^a   Deer, Tim ^b   Du Pen, Stuart ^c   Rauck, Richard ^d   Yaksh, Tony ^e   Hassenbusch, Samuel J ^f  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Center for Pain Relief   (United States)

^c SWEDISH MEDICAL CENTER   (United States)

^d WAKE FOREST BAPTIST HEALTH   (United States)

^e University of California   (United States)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Efficacy; Future research; Intraspinal pharmacology; Intrathecal; Pain; Toxicology

Indexed keywords

ANESTHETIC AGENT; BUPIVACAINE; CLONIDINE; HYDROMORPHONE; MORPHINE;

ANALGESIA; CONFERENCE PAPER; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; PAIN ASSESSMENT; SPINAL ANESTHESIA;

ANALGESICS; HUMANS; INJECTIONS, SPINAL; PAIN;

EID: 0033832253     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(00)00201-3     Document Type: Conference Paper

References (11)

1. Grouls R.J.E., Korsten E.H.M., Yaksh T.L. General considerations in the formulation of drugs for spinal delivery. Yaksh T.L. Spinal Drug Delivery. 1999;371-393 Elsevier, Amsterdam.
2. Giardina KE, Stevens JO, Elsberry DD, Gerhardt GA. Chronic infusion of nonideal solutions into brain parenchyma: effects of pH, osmolarity and flow rate. J Comparative Med (in press).
3. Hassenbusch S.J., Satterfield W.C., Gradert T.L. A sheep model for continuous infusion of test substances. Hum Exp Toxicol. 18:1999;82-87.
4. Drasner K., Sakura S., Chan V.W., Bollen A.W., Ciriales R. Persistent sacral sensory deficit induced by intrathecal local anesthetic infusion in the rat. Anesthesiology. 80:1994;847-852.
5. Barnes R.K., Rosenfeld J.V., Fennessy S.S., Goodchild C.S. Continuous subarachnoid infusion to control severe cancer pain in an ambulant patient. Med J Aust. 161:1994;549-551.
6. Goodchild C.S., Noble J. The effects of intrathecal midazolam on sympathetic nervous system reflexes in man - a pilot study. Br J Clin Pharmacol. 23:1987;279-285.
7. Erdine S., Yucel A., Ozylacin S., Ozyuvaci E., Talu G.K.et al. Neurotoxicity of midazolam in the rabbit. Pain. 80:1999;413-419.
8. Dolan S., Nolan A.M. N-methyl D-aspartate induced mechanical allodynia is blocked by nitric oxide synthase and cyclooxygenase inhibitors. NeuroReport. 10:1999;449-452.
9. Helfaer M.A., Ichord R.N., Martin L.J., Hurn P.D., Castro A., Traytsman R.J. Treatment with the competitive NMDA antagonist GPI 3000 does not improve outcome after cardiac arrest in dogs. Stroke. 29:1998;824-829.
10. Baumgartner WA, Redmond M, Brock M, Tseng E, Blue ME, et al. Pathophysiology of cerebral injury and future management. J Card Surg. 1997;12(2 Suppl.):300-310; discussion in J Card Surg 1997;12(2 Suppl):310-311.
11. Baumgartner WA, Redmond M, Brock M, Tseng E, Blue ME, et al. Pathophysiology of cerebral injury and future management. J Card Surg. 1997;12(2 Suppl.):300-310; discussion in J Card Surg 1997;12(2 Suppl):310-311.